Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia.
Quang VT, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, Freynet N, Parinet V, Leclerc M, Maury S, Solary E, Selimoglu-Buet D, Duployez N, Wagner-Ballon O, Sloma I. Quang VT, et al. Among authors: parinet v. Haematologica. 2023 Nov 1;108(11):3135-3141. doi: 10.3324/haematol.2022.282528. Haematologica. 2023. PMID: 37102610 Free PMC article. No abstract available.
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Decroos A, Cheminant M, Bruneau J, Carras S, Parinet V, Pelletier L, Lacroix L, Martin N, Giustiniani J, Lhermitte L, Asnafi V, Battistella M, Lemonnier F, De Leval L, Sicard H, Bonnafous C, Gauthier L, Genestier L, Caruso S, Gaulard P, Hermine O, Ortonne N. Decroos A, et al. Among authors: parinet v. Haematologica. 2023 Oct 1;108(10):2830-2836. doi: 10.3324/haematol.2022.282220. Haematologica. 2023. PMID: 37165836 Free PMC article. No abstract available.
Long-term outcome after autologous BCR::ABL1-negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study.
Caillot L, Leclerc M, Sleiman EJR, Sloma I, Wagner-Ballon O, Claudel A, Beckerich F, Redjoul R, Robin C, Parinet V, Pautas C, Menouche D, Bouledroua S, Cabanne L, Nait-Sidenas Y, Gautier E, Rouard H, Lafon I, Chalandon Y, Boissel N, Caillot D, Maury S. Caillot L, et al. Among authors: parinet v. Haematologica. 2024 Apr 1;109(4):1264-1268. doi: 10.3324/haematol.2023.283742. Haematologica. 2024. PMID: 38031800 Free PMC article. No abstract available.
Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomes.
Parinet V, Chapiro E, Bidet A, Gaillard B, Maarek O, Simon L, Lefebvre C, Defasque S, Mozziconacci MJ, Quinquenel A, Decamp M, Lifermann F, Ali-Ammar N, Maillon A, Baron M, Martin M, Struski S, Penther D, Micol JB, Auger N, Bilhou-Nabera C, Martignoles JA, Tondeur S, Nguyen-Khac F, Hirsch P, Roos-Weil D; on behalf the FILO (French Innovative Leukemia Organization), GFCH (Groupe Francophone de Cytogénétique Hématologique) groups. Parinet V, et al. J Cell Mol Med. 2021 Oct;25(20):9557-9566. doi: 10.1111/jcmm.16895. Epub 2021 Sep 7. J Cell Mol Med. 2021. PMID: 34492730 Free PMC article.
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT.
Leclerc M, Redjoul R, Le Bouter A, Beckerich F, Robin C, Parinet V, Pautas C, Menouche D, Bouledroua S, Roy L, Cabanne L, Nait-Sidenas Y, Harfouch E, Gautier E, Fourati S, Maury S. Leclerc M, et al. Among authors: parinet v. Lancet Haematol. 2022 May;9(5):e318-e321. doi: 10.1016/S2352-3026(22)00097-7. Epub 2022 Apr 1. Lancet Haematol. 2022. PMID: 35378072 Free PMC article. No abstract available.
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
Redjoul R, Le Bouter A, Parinet V, Fourati S, Maury S. Redjoul R, et al. Among authors: parinet v. Lancet Haematol. 2021 Oct;8(10):e681-e683. doi: 10.1016/S2352-3026(21)00274-X. Epub 2021 Sep 3. Lancet Haematol. 2021. PMID: 34487683 Free PMC article. No abstract available.